Skip to content
10-Q

Quarterly Report

BEONE MEDICINES LTD. BEIGF ONC

0001628280-25-049824

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 1.44B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.49B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.47B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.38B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.36B sh
Capex Q3 2025 · Sep 30, 2025 $148.32M
Capex Q3 2025 · Sep 30, 2024 $400.18M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $710.23M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$215.79M
Short Term Debt Q3 2025 · Sep 30, 2025 $813.3M
Short Term Debt Q3 2025 · Dec 31, 2024 $851.53M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $4.04B
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.63B
Cash And Equivalents Q3 2025 · Sep 30, 2024 $2.7B
Stockholders Equity Q3 2025 · Sep 30, 2025 $4.13B
Stockholders Equity Q3 2025 · Jun 30, 2025 $3.77B
Stockholders Equity Q3 2025 · Mar 31, 2025 $3.5B
Stockholders Equity Q3 2025 · Dec 31, 2024 $3.33B
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.44B
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.37B
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.36B
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.54B
Current Liabilities Q3 2025 · Sep 30, 2025 $2.37B
Current Liabilities Q3 2025 · Dec 31, 2024 $2.21B
Total Liabilities Q3 2025 · Sep 30, 2025 $3.5B
Total Liabilities Q3 2025 · Dec 31, 2024 $2.59B
Current Assets Q3 2025 · Sep 30, 2025 $5.66B
Current Assets Q3 2025 · Dec 31, 2024 $3.99B
Total Assets Q3 2025 · Sep 30, 2025 $7.63B
Total Assets Q3 2025 · Dec 31, 2024 $5.92B
Eps Diluted Q3 2025 · Sep 30, 2025 $0.08
Eps Diluted Q3 2025 · Sep 30, 2025 $0.15
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.36
Eps Basic Q3 2025 · Sep 30, 2025 $0.09
Eps Basic Q3 2025 · Sep 30, 2025 $0.16
Eps Basic Q3 2025 · Sep 30, 2024 −$0.09
Eps Basic Q3 2025 · Sep 30, 2024 −$0.36
Sga Expense Q3 2025 · Sep 30, 2025 $529M
Sga Expense Q3 2025 · Sep 30, 2025 $1.53B
Sga Expense Q3 2025 · Sep 30, 2024 $455.22M
Sga Expense Q3 2025 · Sep 30, 2024 $1.33B
Rd Expense Q3 2025 · Sep 30, 2025 $523.66M
Rd Expense Q3 2025 · Sep 30, 2025 $1.53B
Rd Expense Q3 2025 · Sep 30, 2024 $496.18M
Rd Expense Q3 2025 · Sep 30, 2024 $1.41B
Net Income Q3 2025 · Sep 30, 2025 $124.84M
Net Income Q3 2025 · Sep 30, 2025 $220.43M
Net Income Q3 2025 · Jun 30, 2025 $94.32M
Net Income Q3 2025 · Mar 31, 2025 $1.27M
Net Income Q3 2025 · Sep 30, 2024 −$121.35M
Net Income Q3 2025 · Sep 30, 2024 −$492.91M
Net Income Q3 2025 · Jun 30, 2024 −$120.41M
Net Income Q3 2025 · Mar 31, 2024 −$251.15M
Operating Income Q3 2025 · Sep 30, 2025 $163.11M
Operating Income Q3 2025 · Sep 30, 2025 $262.1M
Operating Income Q3 2025 · Sep 30, 2024 −$120.27M
Operating Income Q3 2025 · Sep 30, 2024 −$488.77M
Gross Profit Q3 2025 · Sep 30, 2025 $1.22B
Gross Profit Q3 2025 · Sep 30, 2025 $3.32B
Gross Profit Q3 2025 · Sep 30, 2024 $831.14M
Gross Profit Q3 2025 · Sep 30, 2024 $2.25B
Revenue Q3 2025 · Sep 30, 2025 $1.41B
Revenue Q3 2025 · Sep 30, 2025 $3.84B
Revenue Q3 2025 · Sep 30, 2024 $1B
Revenue Q3 2025 · Sep 30, 2024 $2.68B